Evidence map›Paper›PMID 39257288›Full record

ArticleJournal of pediatric gastroenterology and nutrition2024

Conference proceedings: Inaugural meeting of the consortium for autism, genetic neurodevelopmental disorders, and digestive diseases.

Alycia Halladay, Joseph Croffie, Julia Dallman, Heidi Grabenstatter, Calliope Holingue, Katie Madgett, Kara G Margolis, Kathleen J Motil, Andres Jimenez-Gomez, Bradley J Ferguson and 5 more

Abstract read
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alycia HalladayAutism Science Foundation, New York, New York, USA.ORCID 0000-0002-8264-8753
Joseph CroffieDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine/Riley Hospital for Children, Indianapolis, Indiana, USA.
Julia DallmanDepartment of Biology, University of Miami, Miami, Florida, USA.
Heidi GrabenstatterAlliance for Genetic Etiologies in Neurodevelopmental Disorders, New York, New York, USA.
Calliope HolingueCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Katie MadgettAutism Science Foundation, New York, New York, USA.
Kara G MargolisNYU Pain Research Center, New York, New York, USA.
Kathleen J MotilUSDA/ARS Children's Nutrition Research Center, Houston, Texas, USA.
Andres Jimenez-GomezNeuroscience Center, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.
Bradley J FergusonDepartments of Health Psychology and Radiology, University of Missouri, Columbia, Missouri, USA.
Baha MoshireeWake Forest University, Winston-Salem, North Carolina, USA.
Kate StillAlliance for Genetic Etiologies in Neurodevelopmental Disorders, New York, New York, USA.
Kent WilliamsNationwide Children's Hospital, Columbus, Ohio, USA.
Gerald Rick UppInternational Foundation for CDKL5 Research, Wadsworth, Ohio, USA.
William BennettAlliance for Genetic Etiologies in Neurodevelopmental Disorders, New York, New York, USA.

Funding

PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAMT32MH014592 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HEATHER E VOLK, Peter P. Zandi · 1985 to 2026
$8.5M
MICROENVIRONMENT IN ENTERIC NEURON DEVELOPMENTR01NS015547 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GERSHON, MICHAEL D, MARGOLIS, KARA GROSS · 1985 to 2022
$7.2M
Global Mental Health Training ProgramT32MH103210 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Judith Karen Bass, Sarah Sutherlin-McIvor Murray · 2015 to 2026
$4.0M
A Prospective Study Examining the Role of Gestational SSRI Exposure in the Development of Functional Gastrointestinal DisordersR01DK130517 · NIDDK · NEW YORK UNIVERSITY · PI MARGOLIS, KARA GROSS, SAVIDGE, TOR C. · 2021 to 2024
$2.5M
Linkage of s100a10 (p11) to enteric 5-HT4-mediated serotonergic signaling roles in GI motility, enteric nervous system development, and co-morbid dysfunction of gut and brainR01DK126644 · NIDDK · NEW YORK UNIVERSITY · PI MARGOLIS, KARA GROSS · 2021 to 2024
$1.9M
Consortium for Autism, Neurodevelopmental Disorders, andDigestive Diseases (CANDID)R13TR003938 · NCATS · PHELAN-MCDERMID SYNDROME FOUNDATION · PI BENNETT, WILLIAM ESTUS, GRABENSTATTER, HEIDI · 2021 to 2021
$22k
Autism Science Foundation 14-100Axial TherapeuticsCureShankDepartment of Defense PR160365Department of Defense W911NF-21-S-0008IDefineIndiana UniversityInternational Foundation for CDKL5 ResearchInternational Rett Syndrome FoundationKirby-Kulkan FamilyNASPGHANNCATS NIH HHS R13 TR003938NIDDK NIH HHS R01 DK126644NIDDK NIH HHS R01 DK130517NIH HHS R13TR003938-01NIH/NCATS R13TR003938NIH NIDDK 1RO1DK130518NIH NIDDK RO1DK126644NIH NINDS RO1NS015547NIMH Global Mental Health Training Research Fellowship 5T32MH103210NIMH NIH HHS T32 MH014592NIMH NIH HHS T32 MH103210NIMH Psychiatric Epidemiology Training Program 5T32MH014592NINDS NIH HHS R01 NS015547Phelan-McDermid Syndrome FoundationRing14 FoundationSimons Foundation 719401The Angelman FoundationThe Center for DiscoveryThe Seidenberg Family Foundation
6 · The paper itself

Abstract

objectivesIndividuals with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), often experience a higher prevalence of gastrointestinal (GI) symptoms but have complex medical and behavioral comorbidities that make diagnosis and treatment difficult. A multi-stakeholder conference was convened to (a) determine patient and family experiences related to GI symptoms in NDDs, (b) review the clinicians' and researchers' perspectives, and (c) determine actionable steps for future research.

methodsThe Consortium for Autism, Neurodevelopmental Disorders and Digestive Diseases (CANDID; www.candidgi.com) virtually over 2 days in 2022 and consisted of four key activities: (1) an electronic family survey to assess underlying NDDs and GI symptoms, (2) a session focused on family perspectives, (3) review current clinical care and research, and (4) discussion to identify key next steps. Survey results were obtained electronically via the REDCap platform, and descriptive statistics were generated. The sessions were recorded, and themes were identified.

resultsThe pre-conference survey ran for ~2 months and 739 families provided responses, with 634 completing all items. 83% had a child with an NDD under age 18, and most patients were White (85%) and non-Hispanic (87%). Constipation (80%), GI reflux disease (51%), and bloating (49%) were the most frequently reported symptoms. Families gave unstructured feedback that the measures used in the surveys were often difficult to answer for patients with NDDs or who were nonspeaking. Family and clinical/scientific sessions identified several common themes, including (1) the need for less invasive diagnostic modalities, (2) the need to validate or adapt existing diagnostic measures (e.g., the Rome IV criteria) and outcome assessments, and (3) the need for enhanced attention to parent and caregiver input in treatment plans.

conclusionsThose providing care to children with NDDs, especially those with communication and cognitive challenges, should be aware of the differing needs in this community and consider family perspectives in managing, treating, and measuring GI issues. Future research should focus on adapting or creating diagnostic and research measures for those with NDDs, developing new diagnostic methods to account for diversity in neurodevelopment and communication, and improving methods for family and caregiver engagement in the care of GI disorders.

Indexed as

Gastrointestinal DiseasesNeurodevelopmental DisordersAutism Spectrum DisorderChildChild, PreschoolCongresses as TopicFemaleHumansautism spectrum disordergastrointestinalrecommendations

Identifiers

PMID39257288
PMCPMC11531374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.